Enliven Therapeutics (ELVN) Income Statement (2019 - 2026)
Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for Enliven Therapeutics (ELVN).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 21M (-2.64%) | 21M (+16.57%) | 18M (-15.17%) | 21M (-13.69%) | 25M (+20.17%) | 21M (-2.54%) | 21M (+12.90%) | 19M (-5.71%) | 20M (+11.50%) | 18M (-8.67%) | 20M (+29.18%) | 15M (+27.78%) | 12M (+44.88%) | 8.20M (+4.73%) | 7.83M (-1.39%) | 7.94M (+12.46%) | 7.06M (-34.99%) | 11M (+4.42%) | 10M (+3.28%) | 10M (+41.43%) | 7.12M (-20.54%) | 8.96M (-5.98%) | 9.53M (+21.09%) | 7.87M (+35.92%) | 5.79M (-2.53%) | 5.94M (+15.56%) | 5.14M (+17.62%) | 4.37M (+22.75%) | 3.56M |
Selling General And Administrative | 7.14M (-45.25%) | 13M (+89.81%) | 6.87M (-3.10%) | 7.09M (+4.26%) | 6.80M (+10.21%) | 6.17M (+6.20%) | 5.81M (+0.52%) | 5.78M (-3.99%) | 6.02M (+24.90%) | 4.82M (+3.88%) | 4.64M (-6.26%) | 4.95M (+9.03%) | 4.54M (+130.46%) | 1.97M (-36.66%) | 3.11M (+187.96%) | 1.08M (-33.33%) | 1.62M (-53.45%) | 3.48M (+6.75%) | 3.26M (+5.16%) | 3.10M (-2.21%) | 3.17M (+22.39%) | 2.59M (-12.50%) | 2.96M (+21.81%) | 2.43M (+55.77%) | 1.56M (+1.30%) | 1.54M (-11.49%) | 1.74M (+46.22%) | 1.19M (+88.89%) | 630K |
Operating Expenses | 28M (-18.84%) | 34M (+36.57%) | 25M (-12.18%) | 29M (-9.81%) | 32M (+17.81%) | 27M (-0.63%) | 27M (+10.04%) | 25M (-5.35%) | 26M (+14.34%) | 23M (-6.27%) | 24M (+20.47%) | 20M (+22.59%) | 16M (+61.61%) | 10M (-7.04%) | 11M (+21.18%) | 9.02M (+3.92%) | 8.68M (-39.43%) | 14M (+4.90%) | 14M (+3.72%) | 13M (+28.11%) | 10M (-11.00%) | 12M (-7.53%) | 12M (+21.26%) | 10M (+40.14%) | 7.35M (-1.74%) | 7.48M (+8.72%) | 6.88M (+23.74%) | 5.56M (+32.70%) | 4.19M |
Depreciation And Amortization | 10K (-87.50%) | 80K (+33.33%) | 60K (-25.00%) | 80K (+14.29%) | 70K (+16.67%) | 60K (-25.00%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (+14.29%) | 70K (0.00%) | 70K | -38.91M | 60K (+20.00%) | 50K (-99.87%) | 39M (+55614.29%) | 70K | - | - | 30K (-57.14%) | 70K | - | - | 20K (-33.33%) | 30K | - | - | - |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -27.82M (-18.84%) | -34.28M (+36.57%) | -25.10M (-12.18%) | -28.58M (-9.81%) | -31.69M (+17.81%) | -26.90M (-0.63%) | -27.07M (+10.04%) | -24.60M (-5.35%) | -25.99M (+14.34%) | -22.73M (-6.27%) | -24.25M (+20.47%) | -20.13M (+22.59%) | -16.42M (+61.61%) | -10.16M (-7.04%) | -10.93M (+21.18%) | -9.02M (+3.92%) | -8.68M (-39.43%) | -14.33M (+4.90%) | -13.66M (+3.72%) | -13.17M (+28.11%) | -10.28M (-11.00%) | -11.55M (-7.53%) | -12.49M (+21.26%) | -10.30M (+40.14%) | -7.35M (-1.74%) | -7.48M (+8.72%) | -6.88M (+23.74%) | -5.56M (+32.70%) | -4.19M |
Ebit | -27.82M (-18.84%) | -34.28M (+36.57%) | -25.10M (-12.18%) | -28.58M (-9.81%) | -31.69M (+17.81%) | -26.90M (-0.63%) | -27.07M (+10.04%) | -24.60M (-5.35%) | -25.99M (+14.34%) | -22.73M (-6.27%) | -24.25M (+20.47%) | -20.13M (+22.59%) | -16.42M (+61.61%) | -10.16M (-7.04%) | -10.93M (+21.18%) | -9.02M (+3.92%) | -8.68M (-39.43%) | -14.33M (+4.90%) | -13.66M (+3.72%) | -13.17M (+28.11%) | -10.28M (-11.00%) | -11.55M (-7.53%) | -12.49M (+21.26%) | -10.30M (+40.14%) | -7.35M (-1.74%) | -7.48M (+8.72%) | -6.88M (+23.74%) | -5.56M (+32.70%) | -4.19M |
EBITDA | -27.81M (-18.68%) | -34.20M (+36.64%) | -25.03M (-12.18%) | -28.50M (-9.87%) | -31.62M (+17.85%) | -26.83M (-0.59%) | -26.99M (+10.07%) | -24.52M (-5.36%) | -25.91M (+14.39%) | -22.65M (-6.29%) | -24.17M (+20.49%) | -20.06M (+22.69%) | -16.35M (-66.68%) | -49.07M (+351.43%) | -10.87M (+21.32%) | -8.96M | 30M | -14.28M (+4.62%) | -13.65M (+3.72%) | -13.16M (+28.39%) | -10.25M (-12.02%) | -11.65M (-6.20%) | -12.42M (+21.76%) | -10.20M (+39.15%) | -7.33M (-6.86%) | -7.87M (+18.88%) | -6.62M (+22.59%) | -5.40M (+28.88%) | -4.19M |
Other Income / Expenses | |||||||||||||||||||||||||||||
Other Non Operating Income | - | -50.00K | - | - | -50.00K | - | - | - | - | -20.00K (+100.00%) | -10.00K | - | - | - | - | -40.00K (-33.33%) | -60.00K (-64.71%) | -170.00K (+750.00%) | -20.00K (-50.00%) | -40.00K (-33.33%) | -60.00K (-57.14%) | -140.00K (+180.00%) | -50.00K (+400.00%) | -10.00K | 10K (-87.50%) | 80K (+700.00%) | 10K (-93.75%) | 160K | - |
Net Income | |||||||||||||||||||||||||||||
Income Before Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.58M | - | - | - | -51.38M | - | - | - | - | - | - | - | - | - | - | - |
Income Tax Expense | - | - | - | - | - | - | - | 230K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -23.63M (-20.36%) | -29.67M (+47.25%) | -20.15M (-20.45%) | -25.33M (-11.25%) | -28.54M (+23.12%) | -23.18M (+0.09%) | -23.16M (+16.09%) | -19.95M (-12.27%) | -22.74M (+17.40%) | -19.37M (-6.74%) | -20.77M (+24.22%) | -16.72M (+13.59%) | -14.72M (+54.14%) | -9.55M (-9.48%) | -10.55M (+18.67%) | -8.89M (+2.54%) | -8.67M (-39.46%) | -14.32M (+4.91%) | -13.65M (+3.72%) | -13.16M (+28.27%) | -10.26M (-10.94%) | -11.52M (-7.25%) | -12.42M (+21.76%) | -10.20M (+41.47%) | -7.21M (-0.55%) | -7.25M (+9.52%) | -6.62M (+22.59%) | -5.40M (+28.88%) | -4.19M |
Net Income | -23.63M (-20.36%) | -29.67M (+47.25%) | -20.15M (-20.45%) | -25.33M (-11.25%) | -28.54M (+23.12%) | -23.18M (+0.09%) | -23.16M (+16.09%) | -19.95M (-12.27%) | -22.74M (+17.40%) | -19.37M (-6.74%) | -20.77M (+24.22%) | -16.72M (+13.59%) | -14.72M (+54.14%) | -9.55M (-9.48%) | -10.55M (+18.67%) | -8.89M (+2.54%) | -8.67M (-39.46%) | -14.32M (+4.91%) | -13.65M (+3.72%) | -13.16M (+28.27%) | -10.26M (-10.94%) | -11.52M (-7.25%) | -12.42M (+21.76%) | -10.20M (+41.47%) | -7.21M (-0.55%) | -7.25M (+9.52%) | -6.62M (+22.59%) | -5.40M (+28.88%) | -4.19M |
Comprehensive Income Net Of Tax | -24.34M (-76.46%) | -103.41M (+423.59%) | -19.75M (-22.55%) | -25.50M (-10.87%) | -28.61M (-67.89%) | -89.11M (+291.35%) | -22.77M (+13.62%) | -20.04M (-12.60%) | -22.93M (-67.90%) | -71.44M (+243.46%) | -20.80M (+23.59%) | -16.83M (+14.33%) | -14.72M (-60.91%) | -37.66M (+256.97%) | -10.55M (+18.67%) | -8.89M (-39.40%) | -14.67M (-71.46%) | -51.40M (+276.56%) | -13.65M (+3.72%) | -13.16M (+28.27%) | -10.26M (-75.21%) | -41.39M (+232.45%) | -12.45M (+22.78%) | -10.14M (+39.67%) | -7.26M (-69.01%) | -23.43M (+255.54%) | -6.59M (+22.04%) | -5.40M (+28.88%) | -4.19M |